CVE-2020-11723

MEDIUMCVSS 5.5/10EPSS 0.45%

Last modified

CVE-2020-11723 is a medium-severity vulnerability rated 5.5/10 on the CVSS scale. Cellebrite UFED 5.0 through 7.29 uses four hardcoded RSA private keys to authenticate to the ADB daemon on target devices. Extracted keys can be used to place evidence onto target devices when performing a forensic extraction.. EPSS estimates a 0.45% chance of exploitation in the next 30 days.

Description

Cellebrite UFED 5.0 through 7.29 uses four hardcoded RSA private keys to authenticate to the ADB daemon on target devices. Extracted keys can be used to place evidence onto target devices when performing a forensic extraction.

Metrics

CVSS 3.1
5.5/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

EPSS Probability
0.45%

35.7th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
CellebriteUfed Firmware>= 5.0, <= 7.29

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2020-11723?
Cellebrite UFED 5.0 through 7.29 uses four hardcoded RSA private keys to authenticate to the ADB daemon on target devices. Extracted keys can be used to place evidence onto target devices when performing a forensic extraction.
How severe is CVE-2020-11723?
CVE-2020-11723 has a CVSS score of 5.5/10 (MEDIUM severity). The EPSS model estimates a 0.45% probability of exploitation in the next 30 days.
How do I fix CVE-2020-11723?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2020-11723?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST